Timothy Gertsch - 11 Sep 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Accounting Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
11 Sep 2023
Net transactions value
-$291,916
Form type
4
Filing time
13 Sep 2023, 19:03:13 UTC
Previous filing
18 Aug 2023
Next filing
17 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $157,325 +17,500 +102% $8.99 34,621 11 Sep 2023 Direct F1
transaction AGL Common Stock Sale $325,778 -17,500 -51% $18.62 17,121 11 Sep 2023 Direct F1, F2
transaction AGL Common Stock Options Exercise $39,375 +8,750 +51% $4.50 25,871 11 Sep 2023 Direct F1
transaction AGL Common Stock Sale $162,838 -8,750 -34% $18.61 17,121 11 Sep 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -17,500 -67% $0.000000 8,750 11 Sep 2023 Common Stock 17,500 $8.99 Direct F4
transaction AGL Options (Rights to Buy) Options Exercise $0 -8,750 -50% $0.000000 8,750 11 Sep 2023 Common Stock 8,750 $4.50 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.61 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.60 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 These options were granted on July 29, 2020, and became vested as of June 29, 2022 and June 29, 2023.
F5 These options were granted on July 29, 2020, and became vested as of June 29, 2023.